Showing results (201-210 of 233) with videos related to
Sort By:
Pageof 24
Journal of Pharmaceutical Sciences|February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubilityJohn Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 23, 2020
Adipocyte-derived SFRP5 inhibits breast cancer cells migration and invasion through Wnt and epithelial-mesenchymal transition signaling pathwaysWenzhong Zhou, Chunmiao Ye, Liang Li, et al.Nature Communications|December 24, 2025
Roles of micro/nanoplastics in the spread of antimicrobial resistance through conjugative gene transferYuanyuan Kang, Shu-Hong Gao, Yusheng Pan, et al.The Journal of Clinical Investigation|January 22, 2015
Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated diseaseJason P Chua, Satya L Reddy, Zhigang Yu, et al.International Journal of Cancer|October 14, 2021
Prognostic value of gamma-interferon-inducible lysosomal thiol reductase expression in female patients diagnosed with breast cancerChunmiao Ye, Wenzhong Zhou, Fei Wang, et al.Acta Neuropathologica|April 20, 2020
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine diseaseSamir R Nath, Matthew L Lieberman, Zhigang Yu, et al.Chinese Medical Journal|February 26, 2024
An advanced machine learning method for simultaneous breast cancer risk prediction and risk ranking in Chinese population: A prospective cohort and modeling studyLiyuan Liu, Yong He, Chunyu Kao, et al.Clinical Pharmacology : Advances and Applications|November 8, 2019
A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese SubjectsChao Liu, Hong Lu, Fei Yuan, et al.Journal of Experimental & Clinical Cancer Research : CR|November 29, 2024
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancerYaxun Guo, Yuzhan Li, Zhongmei Zhou, et al.Experimental and Therapeutic Medicine|September 21, 2018
Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapyLiang Li, Shuchen Liu, Liyuan Liu, et al.Pageof 24